Skip to main content
. 2018 Aug 9;13(8):e0201256. doi: 10.1371/journal.pone.0201256

Fig 2.

Fig 2

Progression-free survival and cancer-specific survival in patients with UTUC according to the expression levels of STAT3 (A, B), S1PR1 (C, D), and IL-6 (E, F).